{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"26.4","upperLimit":"42.3","value":"34.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"137"}],"units":"Participants"}],"description":"Percentage of participants who achieved CR or sCR according to IMWG Uniform Response Criteria for Multiple Myeloma as assessed by an IRC.","dispersionType":"95% Confidence Interval","groups":[{"description":"BB2121","id":"OG000","title":"BB2121"}],"paramType":"NUMBER","populationDescription":"All Treated Participants","reportingStatus":"POSTED","timeFrame":"From first dose to 24 Months","title":"Complete Response Rate","type":"SECONDARY","unitOfMeasure":"Percentage of participants"}